Northern Trust’s Neuronetics STIM Stock Holding History

Northern Trust’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$116K	Sell	89,138 -188,240	-68%	-$274K	﹤0.01%	4094
2026 Q1	$402K	Sell	277,378 -1,022	-0.4%	-$1.62K	﹤0.01%	3696
2025 Q4	$384K	Buy	278,400 +1,790	+0.6%	+$3.75K	﹤0.01%	3755
2025 Q3	$755K	Buy	276,610 +1,226	+0.4%	+$4.36K	﹤0.01%	3516
2025 Q2	$961K	Buy	275,384 +201,415	+272%	+$795K	﹤0.01%	3421
2025 Q1	$272K	Buy	73,969 +17,257	+30%	+$63K	﹤0.01%	3826
2024 Q4	$91.3K	Hold	56,712	–	–	﹤0.01%	4171
2024 Q3	$43.1K	Sell	56,712 -107	-0.2%	-$140	﹤0.01%	4239
2024 Q2	$102K	Sell	56,819 -41	-0.1%	-$118	﹤0.01%	4047
2024 Q1	$271K	Buy	56,860 +7,761	+16%	+$27.3K	﹤0.01%	3787
2023 Q4	$142K	Hold	49,099	–	–	﹤0.01%	4017
2023 Q3	$66.3K	Sell	49,099 -1,181	-2%	-$2.07K	﹤0.01%	4103
2023 Q2	$108K	Sell	50,280 -5,404	-10%	-$13.1K	﹤0.01%	4016
2023 Q1	$162K	Buy	55,684 +492	+0.9%	+$2.48K	﹤0.01%	3933
2022 Q4	$379K	Buy	55,192 +12,230	+28%	+$57.7K	﹤0.01%	3593
2022 Q3	$137K	Sell	42,962 -831	-2%	-$3.02K	﹤0.01%	4016
2022 Q2	$141K	Sell	43,793 -178,318	-80%	-$518K	﹤0.01%	4052
2022 Q1	$673K	Sell	222,111 -10,799	-5%	-$36.5K	﹤0.01%	3617
2021 Q4	$1.04M	Sell	232,910 -12,697	-5%	-$62.2K	﹤0.01%	3524
2021 Q3	$1.61M	Buy	245,607 +7,647	+3%	+$73.3K	﹤0.01%	3379
2021 Q2	$3.81M	Buy	237,960 +196,380	+472%	+$2.71M	﹤0.01%	2998
2021 Q1	$515K	Buy	41,580 +14,160	+52%	+$217K	﹤0.01%	3811
2020 Q4	$305K	Sell	27,420 -1,581	-5%	-$11.9K	﹤0.01%	3858
2020 Q3	$141K	Buy	29,001 +2,145	+8%	+$8.14K	﹤0.01%	3886
2020 Q2	$52K	Sell	26,856 -138,607	-84%	-$284K	﹤0.01%	4051
2020 Q1	$312K	Buy	165,463 +25,216	+18%	+$78.8K	﹤0.01%	3562
2019 Q4	$629K	Sell	140,247 -46,417	-25%	-$288K	﹤0.01%	3511
2019 Q3	$1.55M	Buy	186,664 +53,046	+40%	+$580K	﹤0.01%	3237
2019 Q2	$1.67M	Buy	133,618 +5,877	+5%	+$83.1K	﹤0.01%	3161
2019 Q1	$1.95M	Buy	127,741 +55,543	+77%	+$919K	﹤0.01%	3100
2018 Q4	$1.4M	Sell	72,198 -7,559	-9%	-$166K	﹤0.01%	3235
2018 Q3	$2.56M	Buy	79,757 +69,626	+687%	+$2.12M	﹤0.01%	3081
2018 Q2	$270K	Buy	+10,131	New	+$276K	﹤0.01%	3760

Other funds holding STIM

MAM

Madryn Asset Management New York $36.9M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust's STIM Position: Q2 2026 in Review

Northern Trust reduced its Neuronetics (STIM) stake by 68% in Q2 2026, selling an estimated $274K and leaving 89,138 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #4094.

Northern Trust first reported a position in STIM in Q2 2018 and has held it in 33 quarters since. The position peaked at $3.81M in Q2 2021. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

Northern Trust held 89,138 shares of Neuronetics worth $116K as of Q2 2026.
Northern Trust sold 188,240 Neuronetics shares in Q2 2026, an estimated $274K.
Neuronetics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4094 holding.
Northern Trust first reported a position in Neuronetics in Q2 2018 and has held it in 33 quarters since.
Northern Trust's Neuronetics position peaked at $3.81M in Q2 2021.
87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.